regulatory
confidence high
sentiment negative
materiality 0.65
Aclarion, Inc. (ACON): Nasdaq/NYSE listing notice — Aclarion receives Nasdaq notice for minimum bid price non-compliance; 180-day cure period
Aclarion, Inc.
- Nasdaq notified Aclarion on Dec 20, 2022 that its common stock failed the $1.00 minimum bid price rule for 30 consecutive business days.
- The company has 180 calendar days to regain compliance by closing at $1.00 or more for at least 10 consecutive business days.
- If not cured, Aclarion may be eligible for a second 180-day period if it meets other listing requirements and intends to effect a reverse stock split.
- Company states the notice does not affect business, operations, or SEC reporting requirements.
- Aclarion is considering options to regain compliance and will monitor bid price.